NCT05937685 Reducing Blood Pressure in Patients With High Cardiovascular Risk
| NCT ID | NCT05937685 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Myocardial Infarction |
| Study Type | INTERVENTIONAL |
| Enrollment | 546 participants |
| Start Date | 2023-09-01 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 546 participants in total. It began in 2023-09-01 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are: * Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care? * Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?
Eligibility Criteria
Inclusion Criteria: * Patients of LA General Medical Center, Rancho Los Amigos, Olive Medical Center or Harbor-UCLA Medical Center with ischemic stroke, hemorrhagic stroke, or myocardial infarction * English or Spanish speaking * Systolic blood pressure (SBP) ≥ 130 mm Hg Exclusion Criteria: * Age \< 35 years * SBP \< 130 mm Hg * Only speaks a language other than English or Spanish * Cannot provide informed consent due to dementia or aphasia
Contact & Investigator
Alejandra Casillas, MD
PRINCIPAL INVESTIGATOR
University of California, Los Angeles
Frequently Asked Questions
Who can join the NCT05937685 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, studying Myocardial Infarction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05937685 currently recruiting?
Yes, NCT05937685 is actively recruiting participants. Contact the research team at ayalariv@usc.edu for enrollment information.
Where is the NCT05937685 trial being conducted?
This trial is being conducted at Downey, United States, Los Angeles, United States, Sylmar, United States, Torrance, United States.
Who is sponsoring the NCT05937685 clinical trial?
NCT05937685 is sponsored by University of Southern California. The principal investigator is Alejandra Casillas, MD at University of California, Los Angeles. The trial plans to enroll 546 participants.